World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
82
Citations
40864
World Ranking
15862
National Ranking
7981

James E. Balow publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where James E. Balow sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 235 publications — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

James E. Balow D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where James E. Balow sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 82 D-Index — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

James E. Balow is affiliated with the National Institutes of Health in the United States. Their research work spans multiple fields related to medicine and molecular biology. The primary areas of study include Rheumatology, Molecular Biology, Pathology and Forensic Medicine, Cell Biology, and Public Health, Environmental and Occupational Health.

Their main fields of study cover Medicine and Biochemistry, Genetics, and Molecular Biology. The scientific topics addressed in their publications involve Systemic Lupus Erythematosus Research, Inflammasome and immune disorders, Streptococcal Infections and Treatments, Osteomyelitis and Bone Disorders Research, Renal Diseases and Glomerulopathies, Liver Diseases and Immunity, and Immunodeficiency and Autoimmune Disorders.

James E. Balow has contributed to several notable research papers, including:

  • De novoCIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): A new member of the expanding family of pyrin-associated autoinflammatory diseases (2020, UNC Libraries)
  • Update on scoring and providing evidence basis for assessing pathology in lupus nephritis (2023, Kidney International)
  • Parathyroid Hormone Resistance and Autoantibodies to the PTH1 Receptor (2021, New England Journal of Medicine)
  • The classification of glomerulonephritis in systemic lupus erythematosus revisited (2021, UNC Libraries)
  • A novel variant affecting the cytoplasmic tail of the FAT1 protocadherin causing coloboma and renal failure: A case report (2023, Ophthalmic Genetics)

The scientist frequently collaborates with others in their field. Some of the regular co-authors include Sergio D. Rosenzweig, Surya V. Seshan, Agnes B. Fogo, Ivona Aksentijevich, and Miroslawa Nowak.

James E. Balow's research is published primarily in venues such as UNC Libraries, Kidney International, New England Journal of Medicine, and Ophthalmic Genetics. These publications reflect a focus on both clinical and molecular aspects of autoimmune and inflammatory diseases.

Best Publications

  • The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited

    Jan J. Weening;Vivette D. D'Agati;Melvin M. Schwartz;Surya V. Seshan

  • Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever

    I. Aksentijevich;M. Centola;Z. M. Deng;R. Sood

  • Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs.

    H. A. Austin;J. H. Klippel;J. E. Balow;N. G.H. Le Riche

  • Enzyme replacement therapy in Fabry disease: a randomized controlled trial.

    Raphael Schiffmann;Jeffrey B. Kopp;Howard A. Austin;Sharda Sabnis

  • Glucocorticosteroid Therapy: Mechanisms of Action and Clinical Considerations

    Anthony S. Fauci;David C. Dale;James E. Balow

  • Glucocorticoid Therapy for Immune-Mediated Diseases: Basic and Clinical Correlates

    Dimitrios T. Boumpas;George P. Chrousos;Ronald L. Wilder;Thomas R. Cupps

  • Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium.

    N Zaks;JE Balow;E Mansfield;M. E. Mangelsdorf

  • Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis

    D.T. Boumpas;H.A. Austin;J.E. Balow;E.M. Vaughan

  • Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome.

    Howard A. Austin;Larry R. Muenz;Kathleen M. Joyce;Tatiana T. Antonovych

  • De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases.

    Ivona Aksentijevich;Miroslawa Nowak;Mustapha Mallah;Jae Jin Chae

  • Prognostic factors in lupus nephritis. Contribution of renal histologic data

    Howard A. Austin;Larry R. Muenz;Kathleen M. Joyce;Tatiana A. Antonovych

  • Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis : A randomized, controlled trial

    Mark F. Gourley;Howard A. Austin;Dorothy Scott;Cheryl H. Yarboro

  • A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis.

    Dimitrios T. Boumpas;Richard Furie;Susan Manzi;Gabor G. Illei

  • Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study

    Gabor G. Illei;Yuko Shirota;Cheryl H. Yarboro;Jimmy Daruwalla

  • Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.

    Gabor G. Illei;Howard A. Austin;Marianna Crane;Lee Collins

  • Risk for Sustained Amenorrhea in Patients with Systemic Lupus Erythematosus Receiving Intermittent Pulse Cyclophosphamide Therapy

    Dimitrios T. Boumpas;Howard A. Austin;Ellen M. Vaughan;Cheryl H. Yarboro

  • Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course.

    Mary H Branton;Raphael Schiffmann;Sharda G Sabnis;Gary J Murray

  • Acute tumor lysis syndrome: A review of 37 patients with Burkitt's lymphoma

    Lawrence F. Cohen;James E. Balow;Ian T. Magrath;David G. Poplack

  • Predicting renal outcomes in severe lupus nephritis: Contributions of clinical and histologic data

    Howard A. Austin;Dimitrios T. Boumpas;Ellen M. Vaughan;James E. Balow

  • Methylprednisolone and Cyclophosphamide, Alone or in Combination, in Patients with Lupus Nephritis

    Mark F. Gourley;Howard A. Austin;Dorothy Scott;Cheryl H. Yarboro

Frequent Co-Authors

George C. Tsokos
George C. Tsokos Harvard Medical School
Dimitrios T. Boumpas
Dimitrios T. Boumpas National and Kapodistrian University of Athens
Gabor G. Illei
Gabor G. Illei Horizon Therapeutics
Alfred D. Steinberg
Alfred D. Steinberg Mitre (United States)
Anthony S. Fauci
Anthony S. Fauci Georgetown University
Daniel L. Kastner
Daniel L. Kastner National Institutes of Health
Ivona Aksentijevich
Ivona Aksentijevich National Institutes of Health
Michael D. Lockshin
Michael D. Lockshin Cornell University
Paul H. Plotz
Paul H. Plotz National Institutes of Health
Elon Pras
Elon Pras Tel Aviv University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

While a traditional medical degree remains the main path to becoming a physician in the USA, many students explore related online healthcare degrees for greater flexibility and affordability. Online nursing programs, in particular, have become popular among those aiming to join the healthcare workforce or advance their current roles.

For those seeking to become advanced practice nurses, the cheapest nurse practitioner programs offer a cost-effective route, delivering rigorous training with remote learning options. If you're interested in leadership or specialized nursing roles, pursuing one of the cheapest online msn programs is a smart investment in your future.

Ambitious nurses looking to reach the highest educational level should consider the cheapest dnp programs, which focus on clinical expertise and advanced research skills. Additionally, working RNs aiming to complete their bachelor’s degree without breaking the bank can benefit from cheap rn to bsn online programs.

Exploring these pathways can open doors to diverse healthcare careers while managing costs and scheduling demands, making them ideal choices for many students planning a future in medicine or allied health.

Best Scientists Citing James E. Balow

Trending Scientists

Recently Published Articles